News and events
Find out the latest news and updates about the regulation of therapeutic goods in Australia, as well as events, webinars and consultations with the community.
This page is in Beta testing. We welcome your feedback and suggestions as we look to improve this page.
Industry notices and compliance undertakings
Notifications for sponsors, manufacturers, and advertisers about official decisions and new or updated regulatory requirements, as well as information about recent regulatory compliance and enforcement actions.
-
Regulatory decision notices
Access official regulatory decisions for sponsors, manufacturers and advertisers, including GMP clearances, listing notices, administrative instruments, and updates to regulatory requirements. -
Latest articles
-
Product Information safety updates - June 2026
Information for health professionals about medicines with safety related updates to their Product Information. -
New information relating to s 9D(1) applications for listed medicines
TGA has released a new information page relating to the availability of s 9D(1) of the Act to correct information in the ARTG about listed medicines. -
TGA leads crackdown of illegal nicotine products across Darwin
The TGA, in partnership with NT Health, Northern Territory Police Force and the Northern Territory Department of Trade, Business and Asian Relations, conducted a targeted multi-agency enforcement operation across three premises in Darwin.
Latest publications
-
Advisory Committee on Medicines meeting statement
-
Advisory Committee on Complementary Medicines meeting statement for 26 March 2026
-
Advisory Committee on Medicines meeting statement
Latest consultations
-
We are seeking feedback on proposed changes to improve the Therapeutic Goods Advertising Code.
-
We are seeking feedback on proposed changes to publishing information about Good Manufacturing Practice (GMP) compliance on our website.
-
Have your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), Advisory Committee on Chemicals Scheduling (ACCS), and the joint meeting of the ACMS and ACCS.